πŸ‡ΊπŸ‡Έ FDA
Patent

US 12082566

Rodent animals expressing human CR1

granted A61KA61K49/0008

Quick answer

US patent 12082566 (Rodent animals expressing human CR1) held by REGENERON PHARMACEUTICALS, INC. expires Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Sep 10 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K49/0008